Renaissance Technologies’s Pardes Biosciences, Inc. Common Stock PRDS Stock Holding History

Renaissance Technologies’s Portfolio PRDS Stock Details PRDS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-81,689	Closed	-$148K	–	4282
2023 Q2	$148K	Buy	81,689 +51,189	+168%	+$93.6K	﹤0.01%	3365
2023 Q1	$40K	Buy	30,500 +614	+2%	+$1K	﹤0.01%	3709
2022 Q4	$51K	Buy	+29,886	New	+$37.9K	﹤0.01%	3792

Other funds holding PRDS

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Renaissance Technologies's PRDS Position: Q3 2023 in Review

Renaissance Technologies sold out of Pardes Biosciences, Inc. Common Stock (PRDS) in Q3 2023, closing a stake of 81,689 shares — an estimated $148K sold.

Renaissance Technologies first reported a position in PRDS in Q4 2022 and held it in 3 quarters. The position peaked at $148K in Q2 2023. 1 fund tracked by Wall St. Rank holds PRDS as of Q3 2023.

Renaissance Technologies reported no remaining Pardes Biosciences, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Renaissance Technologies sold 81,689 Pardes Biosciences, Inc. Common Stock shares in Q3 2023, an estimated $148K.
Renaissance Technologies first reported a position in Pardes Biosciences, Inc. Common Stock in Q4 2022 and held it in 3 quarters.
Renaissance Technologies's Pardes Biosciences, Inc. Common Stock position peaked at $148K in Q2 2023.
1 fund tracked by Wall St. Rank held Pardes Biosciences, Inc. Common Stock as of Q3 2023.

Based on Renaissance Technologies's 13F filing for Q3 2023, filed 14 Nov 2023.